Skip to main content
. 2016 Oct 26;22:1267–1279.

Table 4. Variations of CHST6 identified in Turkish MCD patients.

Nucleotide change Amino acid change Variation type Immunotype Patient no Polyphen SIFT HGMD No
c.738 C>G
p.C246W
missense
I
1(1:homozygote)
1
(probably damaging)
0
(not tolerated)
CM065078
c.1 A>T
p. M1L
First codon loss
II
1(2:heterozygote)
MD
MD
CM0650699
c.894_895 insG
p. Q298fs
frameshift
I
5(4,7,11,14,18: homozygote)
MD
MD
Novel
c.610 C>T
p. P204S
missense
I
3(3: homozygote; 6: compound heterozygote
1
(probably damaging)
0,01
(not tolerated)
Novel
c.462_463 del GC
p. R155Afs
frameshift
I
1(6:compound heterozgote)
MD
MD
Novel
c.526 G>A
p. V176M
missense
I,II
2(8,15:homozygote; 9:compound heterozygote)
1
(probably damaging)
0
(not tolerated)
Novel
c. 631 C>T
p. R211W
missense
I
3(10,12,17: homozygote)
1
(probably damaging)
0
(not tolerated)
CM002586
c.164 T>C p. F55S missense I 1(9:compund heterozygote) 0,968
(probably damaging) 0
(not tolerated) Novel